These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20509936)

  • 1. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication.
    Oades RD; Dauvermann MR; Schimmelmann BG; Schwarz MJ; Myint AM
    Behav Brain Funct; 2010 May; 6():29. PubMed ID: 20509936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exploration of the associations of pregnancy and perinatal features with cytokines and tryptophan/kynurenine metabolism in children with attention-deficit hyperactivity disorder (ADHD).
    Oades RD
    Atten Defic Hyperact Disord; 2011 Dec; 3(4):301-18. PubMed ID: 21785943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention.
    Oades RD; Myint AM; Dauvermann MR; Schimmelmann BG; Schwarz MJ
    Behav Brain Funct; 2010 Jun; 6():32. PubMed ID: 20534153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tryptophan metabolic pathway in children with attention deficit hyperactivity disorder with and without comorbid oppositional defiant disorder and conduct disorder.
    Sağlam E; Bilgiç A; Abuşoğlu S; Ünlü A; Sivrikaya A
    Psychiatry Res; 2021 Apr; 298():113770. PubMed ID: 33545424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indole Tryptophan Metabolism and Cytokine S100B in Children with Attention-Deficit/Hyperactivity Disorder: Daily Fluctuations, Responses to Methylphenidate, and Interrelationship with Depressive Symptomatology.
    Fernández-López L; Molina-Carballo A; Cubero-Millán I; Checa-Ros A; Machado-Casas I; Blanca-Jover E; Jerez-Calero A; Madrid-Fernández Y; Uberos J; Muñoz-Hoyos A
    J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):177-188. PubMed ID: 32048862
    [No Abstract]   [Full Text] [Related]  

  • 6. Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs.
    Ouadih-Moran M; Muñoz-Hoyos A; D'Marco L; Molina-Carballo A; Seiquer I; Checa-Ros A
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study.
    Aarsland TI; Landaas ET; Hegvik TA; Ulvik A; Halmøy A; Ueland PM; Haavik J
    Behav Brain Funct; 2015 Nov; 11(1):36. PubMed ID: 26542774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum levels of kynurenine metabolites in paediatric patients affected by ADHD.
    Evangelisti M; De Rossi P; Rabasco J; Donfrancesco R; Lionetto L; Capi M; Sani G; Simmaco M; Nicoletti F; Villa MP
    Eur Child Adolesc Psychiatry; 2017 Dec; 26(12):1433-1441. PubMed ID: 28527020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
    Bilgiç A; Toker A; Işık Ü; Kılınç İ
    Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive Function and Attention Performance in Children with ADHD: Effects of Medication and Comparison with Typically Developing Children.
    Miklós M; Futó J; Komáromy D; Balázs J
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31658722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey matter volumes in treatment naïve vs. chronically treated children with attention deficit/hyperactivity disorder: a combined approach.
    Villemonteix T; De Brito SA; Kavec M; Balériaux D; Metens T; Slama H; Baijot S; Mary A; Peigneux P; Massat I
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1118-27. PubMed ID: 25934396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory.
    Barnett R; Maruff P; Vance A; Luk ES; Costin J; Wood C; Pantelis C
    Psychol Med; 2001 Aug; 31(6):1107-15. PubMed ID: 11513378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.
    Castellanos FX; Lee PP; Sharp W; Jeffries NO; Greenstein DK; Clasen LS; Blumenthal JD; James RS; Ebens CL; Walter JM; Zijdenbos A; Evans AC; Giedd JN; Rapoport JL
    JAMA; 2002 Oct; 288(14):1740-8. PubMed ID: 12365958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An examination of the effects of stimulant medication on response inhibition: a comparison between children with and without attention deficit hyperactivity disorder.
    Brackenridge R; McKenzie K; Murray GC; Quigley A
    Res Dev Disabil; 2011; 32(6):2797-804. PubMed ID: 21700419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder.
    Waxmonsky JG; Pelham WE; Baweja R; Hale D; Pelham WE
    J Pediatr; 2022 Feb; 241():115-125.e2. PubMed ID: 34571023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum S100B in never-medicated and medicated schizophrenic patients.
    Zhang XY; Xiu MH; Song C; Chen DC; Wu GY; Haile CN; Kosten TA; Kosten TR
    J Psychiatr Res; 2010 Dec; 44(16):1236-40. PubMed ID: 20510426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression.
    Yang K; Xie GR; Hu YQ; Mao FQ; Su LY
    J Neural Transm (Vienna); 2008 Dec; 115(12):1687-94. PubMed ID: 18982242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms.
    Schmitt A; Bertsch T; Henning U; Tost H; Klimke A; Henn FA; Falkai P
    Schizophr Res; 2005 Dec; 80(2-3):305-13. PubMed ID: 15964742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.